Price- guaging Big Pharma
Pharma executives have grown so comfortable, and so certain that the Trump Administration will back whatever they do, that they are still pricing Americans out of the life-saving prescriptions they need, and then justifying it in the name of shareholders’ rights. Nirmal Mulye, the CEO of Nostrum Laboratories, was the latest to do so: Nostrum …